The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Open accessAbstract
Desmoplasia describes the deposition of extensive extracellular matrix and defines primary pancreatic ductal adenocarcinoma (PDA). The acellular component of this stroma has been implicated in PDA pathogenesis and is being targeted therapeutically in clinical trials. By analyzing the stromal content of PDA samples from numerous annotated PDA data sets and correlating stromal content with both anatomic site and clinical outcome, we found PDA metastases in the liver, the primary cause of mortality to have less stroma, have higher tumor cellularity than primary tumors. Experimentally manipulating stromal matrix with an anti-lysyl oxidase like-2 (anti-LOXL2) antibody in syngeneic orthotopic PDA mouse models significantly decreased matrix content, led to lower tissue stiffness, lower contrast retention on computed tomography, and accelerated tumor growth, resulting in diminished overall survival. These studies suggest an important protective role of stroma in PDA and urge caution in clinically deploying stromal depletion strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“depletion of stromal fibroblasts through hedgehog inhibition, epithelial sonic hedgehog deletion, stromal ablation, or inhibition of lysyl oxidase like-2 increases tumor access to the blood supply and facilitates metastasis, having deleterious consequences on natural history of the disease159–162”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Self-citationDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194
Self-citation
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Clinical and therapeutic relevance of cancer-associated fibroblasts
Chen, Y., McAndrews, K. M., & Kalluri, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00546-5 · Cited by 1,230
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Cancer associated fibroblasts in cancer development and therapy
Jia, H., Chen, X., Zhang, L., & Chen, M. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01688-0 · Cited by 262
Helms, E. J., Berry, M. W., Chaw, R. C., DuFort, C. C., Sun, D., Onate, M. K., Oon, C., Bhattacharyya, S., Sanford-Crane, H., Horton, W., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0601 · Cited by 238
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Falcomatà, C., Bärthel, S., Schneider, G., Rad, R., Schmidt‐Supprian, M., & Saur, D. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0876 · Cited by 218
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Belhabib, I., Zaghdoudi, S., Lac, C., Bousquet, C., & Jean, C. (2021) · Cancers · doi:10.3390/cancers13143466 · Cited by 206
Kay, E. J., Paterson, K., Riera‐Domingo, C., Sumpton, D. P., Däbritz, J. H. M., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00582-0 · Cited by 190
Chitty, J. L., Yam, M., Perryman, L., Parker, A. L., Skhinas, J. N., Setargew, Y. F. I., Mok, E. T. Y., Tran, E., Grant, R. D., Latham, S. L., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00614-y · Cited by 151
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 162
Perez, V. M., Kearney, J. F., & Yeh, J. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751311 · Cited by 143
Self-citationSetargew, Y. F. I., Wyllie, K., Grant, R. D., Chitty, J. L., & Cox, T. R. (2021) · Cancers · doi:10.3390/cancers13030491 · Cited by 114
Tissue architecture in tumor initiation and progression
Almagro, J., Messal, H. A., Elósegui-Artola, A., van Rheenen, J., & Behrens, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.007 · Cited by 91
Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches
Zhang, Y., Fu, Q., Sun, W., Yue, Q., He, P., Niu, D., & Zhang, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06306-8 · Cited by 88
Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer
Ouellette, J. N., Drifka, C. R., Pointer, K. B., Liu, Y., Lieberthal, T. J., Kao, W. J., Kuo, J. S., Loeffler, A. G., & Eliceiri, K. W. (2021) · Bioengineering · doi:10.3390/bioengineering8020017 · Cited by 82
Alonso‐Nocelo, M., Ruíz-Cañas, L., Sancho, P., Görgülü, K., Alcalá, S., Pedrero, C., Vallespinós, M., López-Gil, J. C., Ochando, M., García-García, E., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325564 · Cited by 86
Liu, H., Shi, Y., & Qian, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.012 · Cited by 78
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Flies, D. B., Langermann, S., Jensen, C., Karsdal, M. A., & Willumsen, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199513 · Cited by 79
Micke, P., Strell, C., Mattsson, J. S. M., Martín-Bernabé, A., Brunnström, H., Huvila, J. K., Sund, M., Wärnberg, F., Pontén, F., Glimelius, B. L. G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103269 · Cited by 65
Cytoskeletal prestress: The cellular hallmark in mechanobiology and mechanomedicine
Chowdhury, F., Huang, B., & Wang, N. (2021) · Cytoskeleton · doi:10.1002/cm.21658 · Cited by 64
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer
Wang, W., Wang, X., Yao, F., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012270 · Cited by 63
Herting, C. J., Karpovsky, I., & Lesinski, G. B. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09988-w · Cited by 60
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Espona‐Fiedler, M., Patthey, C., Lindblad, S., Sarró, I., & Öhlund, D. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116492 · Cited by 62
Greene, M. K., Johnston, M. C., & Scott, C. J. (2021) · Cancers · doi:10.3390/cancers13246175 · Cited by 59
Mucciolo, G., Curcio, C., Roux, C., Li, W. Y., Capello, M., Curto, R., Chiarle, R., Giordano, D., Satolli, M. A., Lawlor, R. T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020395118 · Cited by 54
Carlo, S. E. D., Raffenne, J., Varet, H., Ode, A., Granados, D. C., Stein, M., Legendre, R., Tuckermann, J. P., Bousquet, C., & Peduto, L. (2023) · Nature Immunology · doi:10.1038/s41590-023-01642-7 · Cited by 51
Gampala, S., Shah, F., Lu, X., Moon, H., Babb, O., Ganesh, N. U., Sandusky, G. E., Hulsey, E. L., Armstrong, L., Mosley, A. L., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02046-x · Cited by 45
Self-citationGroup Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 48
Zheng, R., Liu, X., Zhang, Y., Liu, Y., Wang, Y.-P., Guo, S., Jin, X., Zhang, J., Guan, Y., & Liu, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383978 · Cited by 44
Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation
Wang, X., Shi, Z., Luo, J., Zeng, Y., He, L., Chen, L., Yao, J., Zhang, T., & Huang, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.054 · Cited by 43
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
Polani, F., Grierson, P. M., & Lim, K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i18.2105 · Cited by 42
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 45
Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating Cancer-Associated Fibroblasts
Go, Y.-H., Choi, W. H., Bae, W. J., Jung, S., Cho, C., Lee, S. A., Park, J. S., Ahn, J. M., Kim, S. W., Lee, K. J., et al. (2022) · Cancers · doi:10.3390/cancers14092077 · Cited by 39
Ritchie, S., Reed, D. A., Pereira, B., & Timpson, P. (2021) · Faculty Reviews · doi:10.12703/r/10-4 · Cited by 40
Willumsen, N., Jensen, C., Green, G. A., Nissen, N. I., Neely, J., Nelson, D. M., Pedersen, R. S., Frederiksen, P., Chen, I. M., Boisen, M. K., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04226-0 · Cited by 37
LOXL2 in Cancer: A Two-Decade Perspective
Cano, A., Eraso, P., Mazón, M. J., & Portillo, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814405 · Cited by 40
Wei, D., Cheng, X., Du, C., Wang, Y., Sun, J., Li, C., Wu, J., Tian, X., Zhao, Y., Nie, G., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101533 · Cited by 35
Papalazarou, V., Drew, J., Juin, A., Spence, H. J., Whitelaw, J., Nixon, C., Salmerón‐Sánchez, M., & Machesky, L. M. (2022) · Journal of Cell Science · doi:10.1242/jcs.259978 · Cited by 32
Swietlik, J. J., Bärthel, S., Falcomatà, C., Fink, D., Sinha, A., Cheng, J., Ebner, S., Landgraf, P., Dieterich, D. C., Daub, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38171-8 · Cited by 37
Zhang, X., Al-Danakh, A., Zhu, X., Feng, D., Yang, L., Wu, H., Li, Y., Wang, S., Chen, Q., & Yang, D. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10698 · Cited by 36
Remodeling tumor microenvironment with nanomedicines
Martin, J. D., Miyazaki, T., & Cabral, H. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1730 · Cited by 35
Yang, Z., Xue, F. S., Li, M., Zhu, X., Lu, X., Wang, C., Xu, E., Wang, X., Zhang, L., Heng, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.753330 · Cited by 33
Self-citationInteractions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumors
Datta, R., Sivanand, S., Lau, A. N., Florek, L., Barbeau, A. M., Wyckoff, J. B., Skala, M. C., & Heiden, M. G. V. (2022) · Science Advances · doi:10.1126/sciadv.abg6383 · Cited by 34
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Skorupan, N., Domínguez, M. P., Ricci, S. L., & Alewine, C. (2022) · Cancers · doi:10.3390/cancers14174209 · Cited by 35
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Lv, K., & He, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00233-8 · Cited by 36
Cancer as a biophysical disease: Targeting the mechanical-adaptability program
Nguyen, L. T. S., Jacob, M. A. C., Parajón, E., & Robinson, D. N. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.04.039 · Cited by 32
Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?
Zeltz, C., Navab, R., Heljäsvaara, R., Kusche‐Gullberg, M., Lü, N., Tsao, M., & Gullberg, D. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00673-3 · Cited by 31
Rauth, S., Malafa, M. P., Ponnusamy, M. P., & Batra, S. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.005 · Cited by 29
Sato, S., Hiruma, T., Koizumi, M., Yoshihara, M., Nakamura, Y., Tadokoro, H., Motomatsu, S., Yamanaka, T., Washimi, K., Okubo, Y., et al. (2023) · Cancer Science · doi:10.1111/cas.15786 · Cited by 29
Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
Curtain, B. M. M., Quirke, N., Thorpe, S. D., & Gallagher, T. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122711 · Cited by 30
From tensegrity to human organs-on-chips: implications for mechanobiology and mechanotherapeutics
Ingber, D. E. (2023) · Biochemical Journal · doi:10.1042/bcj20220303 · Cited by 27
Pereira, B., Ritchie, S., Chambers, C. R., Gordon, K. A., Magenau, A., Murphy, K. J., Nobis, M., Tyma, V. M., Liew, Y. F., Lucas, M. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1197 · Cited by 25
Kuznetsova, A. V., Попова, О. П., Panchenkov, D. N., Dyuzheva, Т. G., & Aa, I. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00886-1 · Cited by 24
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 24
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC
Liu, X., Shao, Y., Li, Y., Chen, Z., Shi, T., Tong, Q., Zou, X., Ju, L., Pan, J., Zhuang, R., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s504503 · Cited by 22
Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy
Murphy, K. J., Zhu, J., Trpceski, M., Pereira, B., Timpson, P., & Herrmann, D. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220162 · Cited by 19
Mechanical signatures of human colon cancers
Lopez‐Crapez, E., Costa, L., Tosato, G., Ramos, J., Mazard, T., Guiramand, J., Thierry, A. R., Colinge, J., Milhiet, P., & Bénistant, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-16669-3 · Cited by 20
The biology of pancreatic cancer morphology
McDonald, O. G. (2021) · Pathology · doi:10.1016/j.pathol.2021.09.012 · Cited by 18
Tumour microenvironment and heterotypic interactions in pancreatic cancer
Velasco, R. M., García, A. G., Sánchez, P. J., Sellart, I. M., & Lobo, V. J. S.-A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00875-8 · Cited by 18
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Urbanova, M., Cihova, M., Buociková, V., Slopovský, J., Dubovan, P., Pinďák, D., Tomáš, M., García‐Bermejo, L., Rodríguez-Garrote, M., Earl, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115179 · Cited by 19
Chen, F., Fu, Y., Bai, G., Qiu, J., & Hua, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1634413 · Cited by 19
Systematic Analysis of Expression and Prognostic Values of Lysyl Oxidase Family in Gastric Cancer
Wang, L., Cao, S., Zhai, R., Zhao, Y., & Song, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.760534 · Cited by 16
Agostini, A., Orlacchio, A., Carbone, C., & Guerriero, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876291 · Cited by 14
Caston, R. A., Shah, F., Starcher, C. L., Wireman, R., Babb, O., Grimard, M., McGeown, J., Armstrong, L., Tong, Y., Пили, Р., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16132 · Cited by 13
Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape
Salgado-Pascual, A., Zalba, S., Lasarte, J. J., & Garrido, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115760 · Cited by 16
Zhou, M., Zhou, C., Geng, H., Huang, Z., Lin, Z., Wang, Y., Zhu, Y., Shi, J. T., Tan, J., Guo, L., et al. (2024) · Small · doi:10.1002/smll.202406245 · Cited by 15
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
Jungmann, F., Kaissis, G. A., Ziegelmayer, S., Harder, F., von Schilling, C., Yen, H.-Y., Steiger, K., Weichert, W., Schirren, R., Demir, I. E., et al. (2021) · Cancers · doi:10.3390/cancers13092069 · Cited by 14
Self-citationFibrosis in Mesothelioma: Potential Role of Lysyl Oxidases
Perryman, L., & Gray, S. G. (2022) · Cancers · doi:10.3390/cancers14040981 · Cited by 13
Zhang, Y., Dong, Q., An, Q., Zhang, C., Mohagheghian, E., Niu, B., Qi, F., Wei, F., Chen, S., Chen, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202203173 · Cited by 12
Context Matters: Response Heterogeneity to Collagen-Targeting Approaches in Desmoplastic Cancers
Fuller, A. M., & Eisinger‐Mathason, T. S. K. (2022) · Cancers · doi:10.3390/cancers14133132 · Cited by 15
Kong, B., Fan, Q., Wang, X., Zhang, Q. H., & Zhang, G. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i26.3101 · Cited by 12
Amaral, M. J., Amaral, M., Freitas, J. S., Oliveira, R. C., Serôdio, M., Cipriano, M. A., & Tralhão, J. G. (2023) · Diagnostics · doi:10.3390/diagnostics13040655 · Cited by 12
Guo, S., & Wang, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1349308 · Cited by 13
Self-citationCancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma
Affò, S., Sererols-Viñas, L., Garcia‐Vicién, G., Cadamuro, M., Chakraborty, S., & Sirica, A. E. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.07.009 · Cited by 12
The Origin of Stroma Influences the Biological Characteristics of Oral Squamous Cell Carcinoma
Omori, H., Shan, Q., Takabatake, K., Nakano, K., Kawai, H., Sukegawa, S., Tsujigiwa, H., & Nagatsuka, H. (2021) · Cancers · doi:10.3390/cancers13143491 · Cited by 12
The mechanics of anoikis resistance in cancer
Corsini, M., Domenichini, M., Moreschi, E., & Mitola, S. M. F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189498 · Cited by 11
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02778-y · Cited by 9
Kawahara, K., Takano, S., Furukawa, K., Takayashiki, T., Kuboki, S., & Ohtsuka, M. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10142-7 · Cited by 9
Yang, Q., Mao, Y., Han, Y., Li, K., Hu, W., Zhou, J., Gong, X., Huang, S., Zhang, R., Liu, L., et al. (2025) · Research · doi:10.34133/research.0937 · Cited by 8
Peng, X. L., McCabe, I. C., Kharitonova, E. V., Xu, Y., Zhao, R. T., Luan, C., Kearney, J. F., Kren, N. P., Hariharan, A., Lee, J. J., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102611 · Cited by 8
Self-citationMejia, I., Bodapati, S., Chen, K. T., & Díaz, B. (2020) · Biomedicines · doi:10.3390/biomedicines8100401 · Cited by 9
Targeting stiff stroma by neutralizing LOX-mediated matrix crosslinking in pancreatic cancer
Zhang, S., Cai, Z., Jiang, L., Cai, S., Weng, Z., & Jiang, S. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.010 · Cited by 7
Qiao, Y., Yin, H., Zhang, Y., Zhang, J., & Dong, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585858 · Cited by 8
Targets in the Tumour Matrisome to Promote Cancer Therapy Response
Jalil, S. M. A., Henry, J. C., & Cameron, A. J. M. (2024) · Cancers · doi:10.3390/cancers16101847 · Cited by 8
Franco, A., Duryea, J., & McDonald, O. G. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10116-z · Cited by 5
Kay, E. J., Paterson, K., Domingo, C. R., Sumpton, D. P., Daebritz, H., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.30.125237 · Cited by 6
Barrett, A., Maslanka, M. D., Darula, Z., McCabe, M. C., Saviola, A. J., Schmitt, L. R., Weaver, V. M., Pitts, T. M., Messersmith, W. A., & Hansen, K. C. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00125 · Cited by 6
Self-citationNasiraee, M. R., Shahrivari, S., Sayad, S., Mahdavi, H., Saraygord‐Afshari, N., & Bagheri, Z. (2023) · Cytotechnology · doi:10.1007/s10616-023-00578-y · Cited by 5
Liu, J., Lei, B., Yu, X., Li, Y., Deng, Y., Yang, G., Li, Z., Liu, T., & Ye, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888339 · Cited by 6
Bouchart, C., Senar, O. A., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-025-03274-0 · Cited by 4
Rashid, F., & Wang, N. (2026) · Mechanobiology in medicine · doi:10.1016/j.mbm.2026.100179 · Cited by 4
Tumor Microenvironment: Recent Advances in Immunotherapies of Pancreatic Cancer
Thankachan, S. V., Jayaraman, V., Datta, L., Apthi, S., Zaman, B. F., Gurunathan, R., Suresh, A., Chandrakesan, P., Vinayagam, R., Kang, S. G., et al. (2025) · Medicina · doi:10.3390/medicina61101776 · Cited by 5
Mancha, S., Horan, M., Pasachhe, O., Keikhosravi, A., Eliceiri, K. W., Matkowskyj, K. A., Notbohm, J., Skala, M. C., & Campagnola, P. J. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.026 · Cited by 4
Drivers of Pancreatic Cancer: Beyond the Big 4
Porcza, L. M., Ballesteros-Cillero, R., Lam, L. T., Maiello, C., & Leslie, N. R. (2025) · Cancers · doi:10.3390/cancers17142354 · Cited by 5
α11β1: A Mesenchymal Collagen-Binding Integrin with a Central Role in Tissue and Tumor Fibrosis
Zeltz, C., & Gullberg, D. (2023) · Biology of extracellular matrix · doi:10.1007/978-3-031-23781-2_7 · Cited by 3
Cellular mechanometabolism: stimuli and implications
Ortiz, I., Lopez, S., Kondapaneni, R. V., Hernández, J. A., Boone, K., & Reinhart‐King, C. A. (2026) · EMBO Reports · doi:10.1038/s44319-026-00795-4 · Cited by 3
Qu, C., Liu, J., Cen, J., Tian, M., Chai, Y., Xia, P., Zhou, R., Ma, J., Wang, H., Yuan, H., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102843 · Cited by 3
Road Map to Defeat Pancreatic Cancer
Ferguson, L. P., & Tuveson, D. A. (2025) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060624-044323 · Cited by 2
Integrins in Cancer: Refocusing on the Tumor Microenvironment
Zeltz, C., Lü, N., Heljäsvaara, R., & Gullberg, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_11 · Cited by 3
LOXL2 in pancreatic tumourigenesis: the complexity of tumour–stromal crosstalk exemplified
Coffelt, S. B., & Morton, J. P. (2022) · Gut · doi:10.1136/gutjnl-2022-327430 · Cited by 2
Metadata
- Authors
- Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., Pishvaian, M. J., Blais, E. M., Lu, B., Li, M., Hollingsworth, M., Stashko, C., Volmar, K., Yeh, J. J., Weaver, V. M., Wang, Z. J., Tempero, M. A., Weichert, W., & Collisson, E. A.
- Affiliations
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- University Hospital Heidelberg (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Foundation Medicine (United States) (US)
- Johns Hopkins University (US)
- Bristol-Myers Squibb (United States) (US)
- University of Nebraska Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Collisson, Eric A.
- ORCID
- Jiang, Honglin
- Torphy, Robert J.
- Steiger, Katja
- Hongo, Henry
- Kriegsmann, Mark
- Horst, David
- Umetsu, Sarah E.
- Joseph, Nancy M.
- McGregor, Kimberly
- Pishvaian, Michael J.
- Blais, Edik M.
- Lu, Brian
- Li, Mingyu
- Hollingsworth, Michael
- Stashko, Connor
- Yeh, Jen Jen
- Weaver, Valerie M.
- Wang, Zhen J.
- Tempero, Margaret A.
- Weichert, Wilko
- Collisson, Eric A.
- Venue
- Journal of Clinical Investigation
- Published
- 2020-08-04
- Volume
- 130
- Issue
- 9
- Pages
- 4704-4709
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7456216
- OpenAlex
- W3047538947
- Cited by
- 127
- References
- 30
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 14 · 2023: 25 · 2022: 31 · 2021: 24 · 2020: 3
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (R01CA178015, R01CA227807, R01CA222862)
- National Institutes of Health (CA193650, CA199064, NCATS Colorado CTSA TL1 TR002533)
- Deutsche Forschungsgemeinschaft (329628492)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- pancreatic ductal adenocarcinoma, tumor stroma, desmoplasia, extracellular matrix, LOXL2, liver metastasis, tumor cellularity, tissue stiffness, tumor progression, overall survival, syngeneic mouse model
- MeSH terms
- Aged, Animals, Extracellular Matrix, Female, Humans, Male, Mice, Transgenic, Middle Aged, Pancreatic Neoplasms, Stromal Cells, Carcinoma, Pancreatic Ductal, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
